CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade Medpace Holdings Inc - MEDP CFD

304.39
2.47%
Market Trading Hours* (UTC) Opens on Tuesday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.40
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023485 %
Charges from full value of position ($-4.46)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023485%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001262 %
Charges from full value of position ($0.24)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001262%
Overnight fee time 21:00 (UTC)
Min traded quantity 0.1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 312.11
Open 300.4
1-Year Change -25.65%
Day's Range 289.12 - 305.59
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 28, 2025 312.11 -2.79 -0.89% 314.90 316.64 311.55
Mar 27, 2025 316.41 -0.13 -0.04% 316.54 319.33 312.96
Mar 26, 2025 317.69 -6.26 -1.93% 323.95 324.53 315.32
Mar 25, 2025 324.12 -3.76 -1.15% 327.88 331.12 320.70
Mar 24, 2025 330.28 7.34 2.27% 322.94 330.79 322.43
Mar 21, 2025 323.80 7.55 2.39% 316.25 324.09 309.95
Mar 20, 2025 319.57 -0.38 -0.12% 319.95 324.94 319.22
Mar 19, 2025 327.34 5.37 1.67% 321.97 328.72 319.95
Mar 18, 2025 322.70 -2.25 -0.69% 324.95 325.69 321.89
Mar 17, 2025 325.81 2.93 0.91% 322.88 329.88 322.88
Mar 14, 2025 324.67 2.72 0.84% 321.95 328.10 318.05
Mar 13, 2025 317.87 -4.13 -1.28% 322.00 325.32 317.71
Mar 12, 2025 324.65 -3.30 -1.01% 327.95 330.06 320.99
Mar 11, 2025 325.80 -11.58 -3.43% 337.38 338.32 324.74
Mar 10, 2025 337.26 9.45 2.88% 327.81 347.20 327.81
Mar 7, 2025 332.68 9.26 2.86% 323.42 333.26 322.94
Mar 6, 2025 325.19 1.99 0.62% 323.20 330.92 323.20
Mar 5, 2025 328.34 6.39 1.98% 321.95 330.40 321.95
Mar 4, 2025 324.02 6.07 1.91% 317.95 328.04 316.75
Mar 3, 2025 319.12 -6.83 -2.10% 325.95 328.69 318.97

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Medpace Holdings Company profile

About Medpace Holdings Inc

Medpace Holdings, Inc. is a global provider of clinical research-based drug and medical device development services. The Company is focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. It also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Its operations are based in North America, Europe, and Asia.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Medpace Holdings Inc revenues increased 23% to $1.14B. Net income applicable to common stockholders increased 25% to $181.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Amortization decrease of 35% to $5.1M (expense), Stock-based Compensation in SGA decrease of 15% to $5.1M (expense).

Industry: Biotechnology & Medical Research (NEC)

5375 Medpace Way
CINCINNATI
OHIO 45227-1543
US

People also watch

Gold

3,122.75 Price
+1.240% 1D Chg, %
Long position overnight fee -0.0162%
Short position overnight fee 0.0080%
Overnight fee time 21:00 (UTC)
Spread 0.30

XRP/USD

2.10 Price
-1.710% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 0.01045

US100

19,232.60 Price
+0.580% 1D Chg, %
Long position overnight fee -0.0235%
Short position overnight fee 0.0013%
Overnight fee time 21:00 (UTC)
Spread 1.8

ETH/USD

1,826.71 Price
+0.940% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 1.75

Still looking for a broker you can trust?

Join the 710,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading